ÀúºÐÀÚ CMO/CDMO ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
Small Molecule CMO/CDMO Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
»óǰÄÚµå : 1823785
¸®¼­Ä¡»ç : Persistence Market Research
¹ßÇàÀÏ : 2025³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 184 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 7,184,000
Unprintable PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ º¹»ç, ÀμⰡ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 7,295 £Ü 10,492,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.
US $ 8,495 £Ü 12,218,000
PDF & Excel (Corporate User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Persistence Market Research´Â À̹ø¿¡ ¼¼°èÀÇ ÀúºÐÀÚ CMO/CDMO ½ÃÀå¿¡ °üÇÑ ±¤¹üÀ§ÇÑ ¸®Æ÷Æ®¸¦ ¹ßÇàÇß½À´Ï´Ù. ½ÃÀå ¼ºÀå ÃËÁø¿äÀΡ¤µ¿Ç⡤±âȸ¡¤°úÁ¦ µîÀÇ ÁÖ¿ä ½ÃÀå ¿ªÇÐÀ» Á¾ÇÕÀûÀ¸·Î ºÐ¼®Çϰí, ½ÃÀå ±¸Á¶¿¡ °üÇÑ ½ÉÃþ ÀλçÀÌÆ®¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

ÀúºÐÀÚ CMO/CDMO ½ÃÀå - ¸®Æ÷Æ® ¹üÀ§ :

ÀúºÐÀÚ CMO/CDMO ½ÃÀå¿¡´Â ÀúºÐÀÚ ÀǾàǰ Á¦Á¶ À§Å¹ ¹× ½ÃÀå °³¹ß À§Å¹ ¼­ºñ½º°¡ ±¤¹üÀ§ÇÏ°Ô Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¼­ºñ½º´Â Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷À» À§ÇØ ¼³°èµÇ¾úÀ¸¸ç, ÀǾàǰ °³¹ß, Á¦ÇüÈ­, Á¦Á¶, Æ÷Àå¿¡ ´ëÇÑ ¿£µå Åõ ¿£µå ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ´ëÇü Á¦¾à»ç, ½Å»ý ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷, Á¦³×¸¯ Á¦¾à»ç µî ´Ù¾çÇÑ ºÎ¹®¿¡ ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¾Æ¿ô¼Ò½Ì µ¿Çâ, ºñ¿ë È¿À²¼º Çâ»ó, ÀǾàǰ Á¦Çü ¹× Á¦Á¶ Àü¹® Áö½Ä¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

¼¼°è ÀúºÐÀÚ CMO/CDMO ½ÃÀåÀ» ÁÖµµÇÏ´Â ¸î °¡Áö ÁÖ¿ä ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. ºñ¿ëÀû ÀåÁ¡°ú ³ôÀº ¾÷¹« È¿À²¼ºÀ¸·Î ÀÎÇØ ÀǾàǰ Á¦Á¶ °øÁ¤ÀÇ ¾Æ¿ô¼Ò½Ì¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀǾàǰ ½ÂÀÎ °Ç¼ö Áõ°¡¿Í ÀúºÐÀÚ ÀǾàǰÀÇ º¹À⼺À¸·Î ÀÎÇØ Á¦¾à±â¾÷Àº Àü¹® Á¦Á¶ ÆÄÆ®³Ê¸¦ ã°Ô µÇ¾ú½À´Ï´Ù. ¿¬¼Ó »ý»ê ¹× °í¿ª°¡ ¿ø·áÀǾàǰ(HPAPI) Á¦Á¶¿Í °°Àº ÷´Ü Á¦Á¶±â¼úÀÇ ÅëÇÕÀº ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±ÔÁ¦ ´ëÀÀ ¹× GMP(Good Manufacturing Practice) Àü¹® Áö½ÄÀÇ Çʿ伺ÀÌ Àü¹® CMO/CDMO¿ÍÀÇ Á¦ÈÞ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:

À¯¸Á ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí ÀúºÐÀÚ CMO/CDMO ½ÃÀåÀº ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç°ú ÁöÀûÀç»ê±Ç °ü·Ã °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¹Ì±¹ FDA, À¯·´ÀǾàǰû(EMA), ±âŸ ±ÔÁ¦ ´ç±¹¿¡ ´ëÇÑ ´ëÀÀ µî ¼öŹÁ¦Á¶¾÷ü¿¡ ´ëÇÑ º¹ÀâÇÑ ½ÂÀÎ ÇÁ·Î¼¼½º´Â Á¦Á¶ ÀÏÁ¤À» Áö¿¬½Ãų ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦¾àȸ»ç´Â Á¦ 3ÀÚ¿¡°Ô À§Å¹ÇÒ ¶§ ÀÚü Á¦Á¦³ª ±â¼úÀÇ ¾ÈÀü¼º¿¡ ´ëÇÑ ¿ì·Á¿¡ Á÷¸éÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¶ÇÇÑ ¼öŹÁ¦Á¶ ½Ã¼³ÀÇ »ý»ê´É·Â Á¦¾à°ú ÷´Ü ±â¼ú·Â¿¡ µû¸¥ ³ôÀº ºñ¿ëµµ ½ÃÀå ¼ºÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ:

¾Ï ¹× ÁßÃ߽Űæ°è(CNS) Áúȯ°ú °°Àº °íºÎ°¡°¡Ä¡ ¹× Æ´»õ Ä¡·á ºÐ¾ß¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ½ÃÀåÀº Å« ºñÁî´Ï½º ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. °íȰ¼º ÀǾàǰ ¼ººÐ(HPAPI)°ú ³ª³ë ºÐ¼â ¹× ºÐ¹« °ÇÁ¶¿Í °°Àº Ư¼ö Á¦Á¦ ±â¼ú ºÐ¾ßÀÇ ¿ª·® È®´ë´Â À¯¸®ÇÑ ¼ºÀå °¡´É¼ºÀ» °¡Á®´Ù ÁÙ °ÍÀÔ´Ï´Ù. ½ÅÈï ½ÃÀå, ƯÈ÷ ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³·Àº ¿î¿µ ºñ¿ë°ú ¾çÈ£ÇÑ ±ÔÁ¦ ȯ°æÀ¸·Î ÀÎÇØ CMO/CDMO¿¡°Ô Å« ºñÁî´Ï½º ±âȸ°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼öŹÁ¦Á¶ °øÁ¤ÀÇ µðÁöÅÐ Çõ½Å°ú ÀÚµ¿È­ÀÇ ¹ßÀüÀº È¿À²¼º°ú È®À强À» Çâ»ó½ÃÄÑ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®

Á¦4Àå ¼¼°èÀÇ ÀúºÐÀÚ CMO/CDMO ½ÃÀå Àü¸Á :

Á¦5Àå ¼¼°èÀÇ ÀúºÐÀÚ CMO/CDMO ½ÃÀå Àü¸Á : Áö¿ª

Á¦6Àå ºÏ¹ÌÀÇ ÀúºÐÀÚ CMO/CDMO ½ÃÀå Àü¸Á :

Á¦7Àå À¯·´ÀÇ ÀúºÐÀÚ CMO/CDMO ½ÃÀå Àü¸Á :

Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ ÀúºÐÀÚ CMO/CDMO ½ÃÀå Àü¸Á

Á¦9Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ÀúºÐÀÚ CMO/CDMO ½ÃÀå Àü¸Á :

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ÀúºÐÀÚ CMO/CDMO ½ÃÀå Àü¸Á :

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀúºÐÀÚ CMO/CDMO ½ÃÀå Àü¸Á :

Á¦12Àå °æÀï ±¸µµ

Á¦13Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Persistence Market Research has recently published an extensive report on the global Small Molecule CMO/CDMO Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

Small Molecule CMO/CDMO Market - Report Scope:

The Small Molecule CMO/CDMO Market encompasses a broad range of contract manufacturing and contract development services for pharmaceutical small molecules. These services are designed to cater to pharmaceutical and biotechnology companies, providing end-to-end solutions for drug development, formulation, production, and packaging. The market serves various segments, including large pharmaceutical firms, emerging biotech companies, and generic drug manufacturers. Growth is driven by increasing outsourcing trends, cost-efficiency, and the rising demand for specialized expertise in drug formulation and production.

Market Growth Drivers:

Several key factors are driving the global Small Molecule CMO/CDMO Market. The rising demand for outsourcing pharmaceutical manufacturing processes due to cost advantages and operational efficiencies is fueling market growth. Additionally, the increasing number of drug approvals and the growing complexity of small molecule drugs have led pharmaceutical companies to seek specialized manufacturing partners. The integration of advanced manufacturing technologies such as continuous manufacturing and high-potency API (HPAPI) production is further supporting market expansion. Furthermore, regulatory compliance and the need for expertise in Good Manufacturing Practices (GMP) are encouraging companies to collaborate with specialized CMO/CDMOs.

Market Restraints:

Despite promising growth prospects, the Small Molecule CMO/CDMO Market faces challenges related to stringent regulatory requirements and intellectual property concerns. The complex approval processes for contract manufacturers, including compliance with the U.S. FDA, EMA, and other regulatory agencies, can delay production timelines. Additionally, pharmaceutical companies often face concerns about the security of proprietary formulations and technologies when outsourcing to third parties. Market growth can also be hindered by capacity constraints at contract manufacturing facilities and the high costs associated with advanced technological capabilities.

Market Opportunities:

The market presents significant opportunities driven by the increasing demand for high-value and niche therapeutic applications, including oncology and central nervous system (CNS) disorders. The expansion of capabilities in high-potency active pharmaceutical ingredients (HPAPIs) and specialized formulation techniques, such as nano-milling and spray drying, provides lucrative growth potential. Emerging markets, particularly in Asia-Pacific, present significant opportunities for CMO/CDMOs due to lower operational costs and favorable regulatory environments. Additionally, advancements in digital transformation and automation in contract manufacturing processes are improving efficiency and scalability, further driving market growth.

Key Questions Answered in the Report:

Competitive Intelligence and Business Strategy:

Leading players in the global Small Molecule CMO/CDMO Market, including Lonza Group, Catalent Inc., and WuXi AppTec, focus on innovation, capacity expansion, and strategic collaborations to gain a competitive edge. These companies invest in R&D to enhance contract development and manufacturing capabilities while expanding their service portfolios. Collaborations with pharmaceutical firms, biotech startups, and government agencies facilitate market access and support long-term growth. Emphasis on regulatory compliance, high-quality manufacturing standards, and robust marketing strategies fosters market expansion and strengthens brand reputation in the evolving Small Molecule CMO/CDMO Market landscape.

Key Companies Profiled:

Small Molecule CMO/CDMO Market Segmentation

By Product

By Service

By Company Size

By Scale of Operation

By Region

Table of Contents

1. Executive Summary

2. Market Overview

3. Value Added Insights

4. Global Small Molecule CMO/CDMO Market Outlook:

5. Global Small Molecule CMO/CDMO Market Outlook: Region

6. North America Small Molecule CMO/CDMO Market Outlook:

7. Europe Small Molecule CMO/CDMO Market Outlook:

8. East Asia Small Molecule CMO/CDMO Market Outlook:

9. South Asia & Oceania Small Molecule CMO/CDMO Market Outlook:

10. Latin America Small Molecule CMO/CDMO Market Outlook:

11. Middle East & Africa Small Molecule CMO/CDMO Market Outlook:

12. Competition Landscape

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â